Literature DB >> 24070133

Antibiotic induced liver injury: what about children?

Daniele Serranti1, Carlotta Montagnani, Giuseppe Indolfi, Elena Chiappini, Luisa Galli, Maurizio de Martino.   

Abstract

Antimicrobial agents are important causes of drug-induced liver injury. They are responsible for about 45% of cases of drug hepatotoxicity. Hepatic damage mechanisms are intrinsic or idiosyncratic. Usually, antibiotics are responsible for idiosyncratic toxicity. This review summarizes the rate of incidence and clinical features of hepatotoxicity due to antibiotics and chemotherapics, with particular attention to data regarding paediatric population. Liver injury features have been systematically evaluated for the most commonly administered antibiotics and chemotherapics in adults, even though there is little information about other widely used compounds, as cephalosporine or clarithromycin, and about antibiotics active against multi-resistant bacteria, as carbapenems, vancomycin, clindamycin, and linezolid. By contrast, there is an abundance of case reports in paediatrics, but very few structured studies have been carried out in children. Children are an important class of antibiotic users, with specific metabolic characteristics, so more studies on them should be carried out.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24070133     DOI: 10.1179/1973947813Y.0000000090

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  2 in total

1.  A challenge for diagnosing acute liver injury with concomitant/sequential exposure to multiple drugs: can causality assessment scales be utilized to identify the offending drug?

Authors:  Roxanne Lim; Hassan Choudry; Kim Conner; Wikrom Karnsakul
Journal:  Case Rep Pediatr       Date:  2014-11-24

2.  Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases.

Authors:  Carmen Ferrajolo; Katia M C Verhamme; Gianluca Trifirò; Geert W 't Jong; Gino Picelli; Carlo Giaquinto; Giampiero Mazzaglia; Bruno H Stricker; Francesco Rossi; Annalisa Capuano; Miriam C J M Sturkenboom
Journal:  Drug Saf       Date:  2017-04       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.